MetaCap

Evommune (EVMN) News

NYSE: EVMNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.04-0.20 (-2.76%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

EVMN news summary

We found 1 recent headline mentioning Evommune (EVMN): 0 in the past week and 1 in the past 30 days, most often from Business Wire. For price context, EVMN is down 2.76% at $7.04. The most recent story, "Evommune Reports Third Quarter 2026 Financial Results and Provides Business Highlights", was published by Business Wire on Nov 12, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Evommune headlines

Compare EVMN